Skip to main content
. 2020 Oct 30;66(3):127–135. doi: 10.1111/idj.12221

Figure 1.

Figure 1.

The therapeutic target of various host-response modulators including the government ‘approved’ non-antibacterial doxycycline formulation (SDD), as well as CMTs, such as inhibitors of matrix metalloproteinase (MMP) and of inflammatory mediators. IL, interleukin; PGE2, prostaglandin E2; PUFAs, polyunsaturated fatty acids. Significantly modified from Golub LM, Ryan ME and Williams RC (18). Modulation of the host response in the treatment of periodontitis. Dent. Today 17:102-109.